Production (Stage)
Barinthus Biotherapeutics plc
BRNS
$0.8824
$0.05246.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.74% | -22.12% | -33.81% | -31.93% | -32.07% |
| Total Receivables | -39.66% | -10.08% | 256.88% | 62.54% | 85.76% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.61% | 8.46% | 56.63% | 15.54% | -3.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 13.19% | 41.25% | 30.70% | -58.24% | 178.24% |
| Total Current Assets | -23.23% | -19.86% | -21.28% | -28.63% | -28.67% |
|
|
|||||
| Total Current Assets | -23.23% | -19.86% | -21.28% | -28.63% | -28.67% |
| Net Property, Plant & Equipment | -46.91% | -39.40% | -8.00% | -14.92% | -7.32% |
| Long-term Investments | -- | -- | 0.00% | 0.00% | 0.00% |
| Goodwill | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -13.00% | -12.59% | -12.21% | -11.84% | -11.51% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.92% | -0.11% | -12.23% | -11.93% | -13.91% |
| Total Assets | -28.82% | -25.26% | -17.95% | -24.13% | -23.81% |
|
|
|||||
| Total Accounts Payable | 16.78% | 54.53% | -40.21% | 5.23% | -73.15% |
| Total Accrued Expenses | -13.59% | 3.40% | -33.19% | 20.25% | 42.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.67% | 7.56% | 32.31% | 68.81% | 194.14% |
| Total Finance Division Other Current Liabilities | 1.88% | -- | -- | -- | 23.30% |
| Total Other Current Liabilities | 1.88% | -- | -- | -- | 23.30% |
| Total Current Liabilities | -6.69% | 24.28% | -18.83% | 28.72% | 7.07% |
|
|
|||||
| Total Current Liabilities | -6.69% | 24.28% | -18.83% | 28.72% | 7.07% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.61% | -9.87% | -4.63% | -3.53% | 8.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.66% | 19.51% | -24.43% | -32.57% | -40.29% |
| Total Liabilities | -3.87% | 9.75% | -14.95% | 4.51% | -2.76% |
|
|
|||||
| Common Stock & APIC | 1.34% | 1.78% | 1.60% | 1.20% | 1.36% |
| Retained Earnings | -33.96% | -34.59% | -36.30% | -43.92% | -58.19% |
| Treasury Stock & Other | 14.79% | -10.99% | 50.13% | -6.22% | 13.86% |
| Total Common Equity | -32.79% | -30.39% | -18.48% | -27.90% | -26.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -32.79% | -30.39% | -18.48% | -27.90% | -26.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -45.90% | -49.76% | -18.54% | -32.02% | -31.72% |
| Total Equity | -32.80% | -30.41% | -18.48% | -27.90% | -26.35% |
|
|
|||||